Scancell in-licenses Vaccitech’s SNAPvax tech for cancer study
Scancell Holdings plc, a developer of immunotherapies, today (November 7) announced it has in-licensed the…
November 7, 2022 - 3 minutes
Scancell
First patient enrolled and dosed on expansion phase of cancer treatment trial
The first patient in an expansion phase of a trial looking at cancer drug Modi-1…
October 31, 2022 - 3 minutes
Scancell signs agreement with Genmab
Scancell Holdings plc, the developer of novel immunotherapies for the treatment of cancer and infectious…
October 26, 2022 - 2 minutes
Cancer Research UK Cuts Two Biotech Collaborations Amid Pandemic Squeeze
The major research funder CRUK and two of the biotech companies it works with have…
February 16, 2021 - 4 minutes
Scancell and BioNTech Will Combine Their Expertise to Fight Cancer
Scancell has brought in BioNTech to develop T-cell receptors against specific target proteins in cancer…
January 9, 2018 - 3 minutes
